Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery

Circulation

Volumn 118, Issue 16, 2008, Pages 1619-1625

  Fleming, Gregory A ^a   Murray, Katherine T ^a   Yu, Chang ^a   Byrne, John G ^a   Greelish, James P ^a   Petracek, Michael R ^a   Hoff, Steven J ^a   Ball, Stephen K ^a   Brown, Nancy J ^a,b   Pretorius, Mias ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Inotropic agents; Surgery

Indexed keywords

ADRENALIN; ALDOSTERONE RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MILRINONE; NORADRENALIN; PROTAMINE; CARDIOTONIC AGENT;

ADULT; ARTICLE; CONTINUOUS INFUSION; ELECTROCARDIOGRAM; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SINUS RHYTHM; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTIVE SURGERY; LENGTH OF STAY; LUNG WEDGE PRESSURE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CORONARY DISEASE; FEMALE; HUMANS; HYPERTENSION; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MILRINONE; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PULMONARY WEDGE PRESSURE; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 55949085602     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.790162     Document Type: Article

References (28)

1. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ, Jr., Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation. 1996;94:390-397.
2. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, Browner WS. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization: MultiCenter Study of Perioperative Ischemia Research Group. JAMA. 1996;276:300-306.
3. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720-1729.
4. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Semi GK, Grover FL, Hammermeister KE. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997:226:501-511.
5. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539-549.
6. Banach M, Rysz J, Drozdz JA, Okonski P, Misztal M, Barylski M, Irzmanski R, Zaslonka J. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J. 2006;70:438-441.
7. Echahidi N, Monty D, Pibarot P, Despres JP, O'Hara G, Champagne J, Philippon F, Daleau P, Voisine P, Mathieu P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation. 2007;116(suppl I):I-213-I-219.
8. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) study. Circulation. 2006;114:1455-1461.
9. Amar D. Perioperative atrial tachyarrhythmias. Anesthesiology. 2002;97: 1618-1623.
10. Argalious M, Motta P, Khandwala F, Samuel S, Koch CG, Gillinov AM, Yared JP, Starr NJ, Bashour CA. "Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med. 2005;33:1327-1332.
11. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:306-315.
12. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.
13. Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471-479.
14. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-1379.
15. Kaiman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, Tonkin AM. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg. 1995;60:1709-1715.
16. Hogue CW Jr, Domitrovich PP, Stein PK, Despotis GD, Re L, Schuessler RB, Kleiger RE, Rottman JN. RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery. Circulation. 1998;98:429-434.
17. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004:CD003611.
18. Sampson KJ, Terrenoire C, Cervantes DO, Kaba RA, Peters NS, Kass RS. Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse. J Physiol. 2008;586:627-637.
19. 2+ handling in human chronic atrial fibrillation. Circulation. 2006;114:670-680.
20. Patterson E, Yu X, Huang S, Garrett M, Kem DC. Suppression of autonomic-mediated triggered firing in pulmonary vein preparations, 24 hours postcoronary artery ligation in dogs. J Cardiovasc Electrophysiol. 2006;17:763-770.
21. 2+ releases. Circ Res. 2008;102:761-769.
22. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000;69:823-828.
23. Tuman KJ, McCarthy RJ, March RJ, Najafi H, Ivankovich AD. Morbidity and duration of ICU stay after cardiac surgery: a model for preoperative risk assessment. Chest. 1992;102:36-44.
24. Vogt PR, Brunner-LaRocca HP, Rist M, Zund G, Genoni M, Lachat M, Niederhauser U, Turina MI. Preoperative predictors of recurrent atrial fibrillation late after successful mitral valve reconstruction. Eur J Cardiothorac Surg. 1998;13:619-624.
25. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340:839-846.
26. Marin F, Pascual DA, Roldan V, Arribas JM, Ahumada M, Tornel PL, Oliver C, Gomez-Plana J, Lip GY, Valdes M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006;97:55-60.
27. Welke KF, Peterson ED, Vaughan-Sarrazin MS, O'Brien SM, Rosenthal GE, Shook GJ, Dokholyan RS, Haan CK, Ferguson TB Jr. Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001. Ann Thorac Surg. 2007;84:1538-1546.
28. Denault AY, Lamarche Y, Couture P, Haddad F, Lambert J, Tardif JC, Perrault LP. Inhaled milrinone: a new alternative in cardiac surgery? Semin Cardiothorac Vasc Anesth. 2006;10:346-360.